Renal Cancer - Results from #5960

Potential Approaches and Recent Advances in Biomarker Discovery in Clear-Cell Renal Cell Carcinoma November 4, 2015

One-Carbon Metabolic Factors and Risk of Renal Cell Cancer: A Meta-Analysis November 4, 2015

Predictors of Postoperative Complications in Patients Who Undergo Radical Nephrectomy and IVC Thrombectomy: A Large Contemporary Tertiary Center Analysis November 4, 2015

Phase II clinical trial of sorafenib plus interferon-alpha treatment for patients with metastatic renal cell carcinoma in Japan November 4, 2015

Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism November 3, 2015

Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases November 3, 2015

Comparison of Postoperative Complications and Mortality Between Laparoscopic and Percutaneous Local Tumor Ablation for T1a Renal Cell Carcinoma: a Population-Based Study November 2, 2015

DNA repair system and renal cell carcinoma prognosis: under the influence of NBS1 October 29, 2015

Optimizing systemic therapy for metastatic renal cell carcinoma beyond the first-line setting October 29, 2015

Sunitinib-associated hypertension and neutropenia as efficacy biomarkers in metastatic renal cell carcinoma patients October 28, 2015

Gender Specific Mutation Incidence and Survival Associations in Clear Cell Renal Cell Carcinoma (CCRCC) October 28, 2015

A Collision Tumor of Papillary Renal Cell Carcinoma and Oncocytoma: Case Report and Literature Review October 27, 2015

Partial nephrectomy for T1 renal cancer can achieve an equivalent oncological outcome to radical nephrectomy with better renal preservation: the way to go October 27, 2015

Is Extensive Parenchymal Resection During Robotic Partial Nephrectomy Justified? A Match Paired Comparison of Two Extirpative Surgical Modalities for Treatment of a Complex Renal Neoplasm October 27, 2015

Preclinical evidence that trametinib enhances the response to anti-angiogenic tyrosine kinase inhibitors in renal cell carcinoma October 27, 2015

Prognostic factors in second-line targeted therapy for metastatic clear-cell renal cell carcinoma after progression on an anti-vascular endothelial growth factor receptor tyrosine kinase inhibitor October 26, 2015

Genomic characterisation of two cancers of unknown primary cases supports a kidney cancer origin October 26, 2015

Validation of a short questionnaire to measure symptoms and functional limitations associated with hand-foot syndrome and mucositis in patients with metastatic renal cell carcinoma October 22, 2015

The potential of radiotherapy to enhance the efficacy of renal cell carcinoma therapy October 21, 2015

IL-37 mediates the antitumor activity in renal cell carcinoma October 21, 2015

Page 299 of 456